Beranda › Kanker Paru › California › Anaheim
Uji klinis Kanker Paru di Anaheim, CA
4 studi untuk Kanker Paru mencari peserta di lokasi sekitar Anaheim (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Kaiser Permanente-Anaheim, Anaheim
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Oncura Health - Anaheim, Anaheim
Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)
Menerima peserta
- UCI Health Family Health Center - Anaheim, Anaheim
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2/3
- Kaiser Permanente-Anaheim, Anaheim
Uji klinis Kanker Paru di kota lain
- Houston, TX78 studi
- Boston, MA62 studi
- New York City, NY60 studi
- Los Angeles, CA45 studi
- Arlington, VA41 studi
- Washington, DC41 studi
- Chicago, IL41 studi
- Nashville, TN40 studi
- Baltimore, MD40 studi
- St. Louis, MO39 studi
- Columbus, OH37 studi
- Philadelphia, PA36 studi
Studi lain di Anaheim
- Skizofrenia8 studi
- Kanker Paru Non-Sel Kecil8 studi
- Penyakit Alzheimer7 studi
- Kolitis Ulseratif7 studi
- Penyakit Crohn6 studi
- Kanker Payudara5 studi
- Obesitas4 studi
- Migrain4 studi
- Gangguan Psikotik4 studi
- Gangguan Bipolar4 studi
- Kanker Metastatik3 studi
- Leukemia Limfositik Kronis3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.